CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Tyler Park

    CRI Funded Scientist

    Tyler Park, PhD

    Immune tolerance protects the body from autoimmune disease by preventing the immune system from attacking normal tissues….
  • Rongting Huang

    CRI Funded Scientist

    Rongting Huang, PhD

    Endometrial cancer is the most common gynecologic malignancy and claims thousands of lives annually. More than 50%…
  • Linglin Huang

    CRI Funded Scientist

    Linglin Huang, PhD

    The immune system plays a vital role in detecting and eliminating cancer, but tumors often evolve ways…
  • Samira Ghazali

    CRI Funded Scientist

    Samira Ghazali, PhD

    Regulatory T cells (Tregs) are essential for keeping the immune system in check, however, in cancer, these…
  • Kai Xu

    CRI Funded Scientist

    Kai Xu, PhD

    The immune system’s ability to make more effective antibodies depends on a process called somatic hypermutation (SHM),…
  • Kristen Witt

    CRI Funded Scientist

    Kristen Witt, PhD

    Nucleic acid sensing is a critical immune defense that detects foreign genetic material from viruses or damaged…
  • Fiona Raso

    CRI Funded Scientist

    Fiona Raso, PhD

    Every day, the immune system works to protect the body from disease-causing pathogens. To achieve this, immune…
  • Tara Muijiwijk

    CRI Funded Scientist

    Tara Muijlwijk, PhD

    Melanoma is an aggressive form of skin cancer that can become life-threatening when it spreads, or metastasizes,…
  • Shannon McGettigan

    CRI Funded Scientist

    Shannon McGettigan, PhD

    Multiple myeloma (MM) is a deadly cancer of plasma cells, and despite current therapies that reduce tumor…
Previous Page
1 … 5 6 7 8 9 … 29
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute